4//SEC Filing
Wynholds Kristin 4
Accession 0000899243-22-013366
CIK 0001832415other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:45 PM ET
Size
5.6 KB
Accession
0000899243-22-013366
Insider Transaction Report
Form 4
Wynholds Kristin
Chief Product Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-04-01+116,700→ 116,700 totalExercise: $1.97Exp: 2032-03-31→ Common Stock (116,700 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/4 of the shares subject to the stock option on April 1, 2023 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on April 1, 2022.
Documents
Issuer
Better Therapeutics, Inc.
CIK 0001832415
Entity typeother
Related Parties
1- filerCIK 0001889329
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:45 PM ET
- Size
- 5.6 KB